| abstract |
The invention relates to novel β-alanine derivatives of general formula (I), wherein Q1, Q2, Q3, Q4, R?1, R2, R3, R4, R5, R6¿ and n have the meaning cited in patent claim 1 and to their physiologically acceptable salts or solvates. Said substances are integrin inhibitors and can be used in the treatment of thrombosis, heart infarct, coronary heart diseases, arteriosclerosis, inflammations, tumors, osteoporosis, infections and restenosis after angioplasty or in pathological processes induced or propagated by angiogenesis. |